Introduction
============

The degeneration and loss of neural retinal cells, especially retinal ganglion cells (RGCs) and photoreceptor cells, is a common result of many retina-related diseases, including glaucoma, age-related macular degeneration, and diabetic retinopathy. Millions of people in the world suffer blindness as a result of retinal cell loss. At present, no treatment can reverse the degeneration of neural retinal cells. In recent laboratory research, replacement therapy of lost retinal cells by stem cell transplantation has proven to be promising. Among various stem cells, retinal progenitor cells (RPCs) are among the best seed cells for attaining functional integration after transplantation \[[@r1]-[@r3]\].

In the past thirty years, great work has been done in exploring the in vivo behavior of RPCs. The competence of RPCs changes in an evolutionarily conserved temporal sequence during retinal development \[[@r4]\]. In early embryonic stages, RPCs mainly give birth to retinal ganglion cells (RGCs), cone photoreceptors, horizontal cells, and amacrine cells, while in late embryonic and neonatal stages, RPCs mainly produce rod photoreceptors, bipolar cells, and Muller cells \[[@r5]-[@r7]\]. In the determination of RPC competence, intracellular gene expression, especially that of transcription factors, plays a fundamental role \[[@r4],[@r8]-[@r10]\]. Since competence is one of the most valuable biologic parameters in stem cell applications, the changing competence of RPCs reminds us of the importance of selecting right-timing RPCs \[[@r1],[@r11],[@r12]\].

RPCs mainly reside in either the embryonic retina or the adult ciliary margin zone \[[@r13]-[@r15]\]. Harvesting sufficient RPCs is necessary for in vivo transplantation, but is often difficult. Therefore, the proliferation culture of RPCs in vitro is necessary in many situations. However, it is still unclear whether and how the competence changes in proliferation-cultured RPCs.

Mice at embryonic day E13.5 and E17.5 represent two stages in retinal development. E13.5 is in the early developmental stages, during which the generation of early retinal cells, especially RGCs, is vigorous. E17.5 is in the late stages, during which the birth of rod photoreceptors, bipolar cells, and glial cells is speeding up \[[@r5],[@r6]\].

To improve the selection of the right-timing RPCs for replacement therapy, we compared the gene expression and the differentiation capacity of E13.5 and E17.5 RPCs. Both freshly-harvested and in vitro-cultured RPCs were investigated to inspect whether the competence of RPCs changed not only with development, but also with the duration of in vitro culture.

Methods
=======

Animal preparation and cell culture
-----------------------------------

Pregnant mice (SPF grade) were obtained from the Center of Experimental Animals Sun Yat-sen University, China. Thirty-two pregnant mice were used in the study. All experimental procedures were conducted in conformity with the institutional guidelines for the care and use of laboratory animals in Zhongshan Ophthalmic Center, Sun Yat-sen University, and complied with the ARVO Statement for the Use of Animals in Ophthalmic and Visual Research.

At E13.5 or E17.5, the pregnant mice were euthanized by cervical vertebra dislocation. The harvesting and culture of retinal progenitor cells was done according to Wang \[[@r5]\] and Yao \[[@r16]\] with minimal modification. Briefly, the anterior eye segment was removed from each of the embryonic mice under a dissecting microscope (MZ6, Leica, Bensheim, Germany), and the neural retinal tissue was separated from the pigmented epithelial layer. The neural retinal tissue was then digested using TrypLE Express (Gibco, Grand Island, NY) for 10 min at 37 °C and then stopped with Dulbecco's Modified Eagle Medium (DMEM)/F12. After centrifugation, cell pellets were resuspended with neural growth medium and dissociated by pipetting repeatedly through a fire-polished pipette. The cell suspension was then seeded onto an uncoated 6-well plate at a density of 2×10^5^ cells/ml and cultured in a 37 °C incubator containing 5% CO~2~. The neural growth medium for RPC proliferation was serum free and composed of DMEM/F12, 1% GlutaMax (Gibco), 2% B27 supplement (Gibco), 1% N2 supplement (Gibco), 20 ng/ml bFGF (R&D Systems, Minneapolis, MN), and 20 ng/ml EGF (PeproTech, Rocky Hill, NJ). EGF and bFGF were added to the medium every 3 days.

In this study, two kinds of culture methods were adopted for RPCs. For proliferation culture, RPCs were seeded onto an uncoated plate and cultured with neural growth medium. The differentiation culture was following established procedure \[[@r17],[@r18]\], with minimal modification. Briefly, RPCs were dissociated by trypsinization and pipetting, and then 1×10^4^ cells were plated onto Poly-D-lysine (PDL)-coated coverslips and cultured in a modified neural growth medium with bFGF and EGF removed and supplemented with 2% fetal bovine serum (FBS).

Real-time quantitative reverse transcription-PCR
------------------------------------------------

Total RNA was collected from freshly harvested or cultured RPCs. The procedure for extracting total RNA was performed according to the instructions in the RNeasy Mini Kit (Qiagen, Hilden, Germany). DNase І (Sigma, St. Louis, MO) treatment was then used to reduce the likelihood of genomic DNA contamination. cDNA was synthesized using the PrimeScript RT reagent Kit (TaKaRa, Tokyo, Japan). For quantitative PCR, SYBR Premix Ex Taq (Takara) was used. In each PCR reaction system (20 μl), the mixture contained cDNA template (approximately 50 ng), SYBR Premix Ex Taq, forward and reverse primers (0.2 μm), and ROX Reference Dye. The reaction was conducted in an ABI Prism 7000 Real-Time PCR System with the following program: 1×95 °C, 10 s; 1×95 °C, 5 s; 40×60 °C, 31 s. After amplification, melting curve analysis was performed to confirm the specificity of PCR products. [Table 1](#t1){ref-type="table"} shows the primer pairs used in the experiment. The expression level of each gene was calculated by normalizing it with the *GAPDH* gene, which served as an internal reference, as reported in \[[@r19]\]. The mRNA level of each gene (x) relative to *GAPDH* was calculated as follows \[[@r20]\]: mRNA (x/*GAPDH*)=2^Ct(^*^GAPDH^*^)-Ct(x)^. The relative mRNA level between different samples (a and b, for example) was calculated as follows: mRNA (a/b)=2^ΔCt(b)-ΔCt(a)^; ΔCt(a,b)=Ct~(x)~-Ct~(GAPDH)~. Data was analyzed using STATA 10.0.

###### Sequence of primer pairs used in real-time quantitative RT--PCR

  **Gene**                       **Primer sequence (5′-3′)**    **Product (bp)**   **GenBank accession number**                                 **Gene function**
  ------------------------------ ------------------------------ ------------------ ------------------------------------------------------------ -------------------------------------------
  *Pax6*                         F: CAGCTTCACCATGGCAAACAAC      116                [NM_013627](http://www.ncbi.nlm.nih.gov/nuccore/146134521)   RPCs development \[[@r4]\]
  R: AGGTATCATAACTCCGCCCATTCA                                                                                                                   
  *Rx1*                          F: CTTACCAACTGCACGAGCTGGA      137                [NM_013833](http://www.ncbi.nlm.nih.gov/nuccore/89274178)    RPCs development \[[@r4]\]
  R: CTTAGCCCGTCGGTTCTGGA                                                                                                                       
  *Nestin*                       F: GGGCCAGCACTCTTAGCTTTGATA    105                [NM_016701](http://www.ncbi.nlm.nih.gov/nuccore/50363231)    Neural progenitors marker
  R: TGAGCCTTCAGGGTGATCCAG                                                                                                                      
  *Nfl*                          F: TCAATGTCAAGATGGCCTTGGA      99                 [NM_010910](http://www.ncbi.nlm.nih.gov/nuccore/39204498)    Immature neuron marker
  R: TTATGCTACCCACGCTGGTGAA                                                                                                                     
  *Math5*                        F: GAAGCTGTCCAAGTACGAGACACTG   100                [NM_016864](http://www.ncbi.nlm.nih.gov/nuccore/8392931)     RGCs development \[[@r33],[@r34]\]
  R: GTGAGCGCGATGATGTAGCTG                                                                                                                      
  *Brn3b*                        F: CGATGCGGAGAGCTTGTCTTC       132                [NM_138944](http://www.ncbi.nlm.nih.gov/nuccore/47059066)    RGCs development \[[@r33],[@r35]\]
  R: GATGGTGGTGGTGGCTCTTACTCT                                                                                                                   
  *Islet1*                       F: CAGACCACGATGTGGTGGAGA       109                [NM_021459](http://www.ncbi.nlm.nih.gov/nuccore/162287064)   RGCs development \[[@r33]\]
  R: TGCCTAGCCGAGATGGGTTC                                                                                                                       
  *GFAP*                         F: ACCAGCTTACGGCCAACAGTG       139                [NM_010277](http://www.ncbi.nlm.nih.gov/nuccore/196115301)   Glial cells development
  R: TGTCTATACGCAGCCAGGTTGTTC                                                                                                                   
  *Nrl*                          F: ACGACCTGGGCAGTAGTCTCAA      109                [NM_008736](http://www.ncbi.nlm.nih.gov/nuccore/196115301)   Rod photoreceptors development \[[@r36]\]
  R: GTGTCGGAAGTCATCCAGTTCAA                                                                                                                    
  *Thy1*                         F: CACCAAGGATGAGGGCGACTA       118                [NM_009382](http://www.ncbi.nlm.nih.gov/nuccore/134152684)   Synaptogenesis \[[@r37],[@r38]\]
  R: GCTTATGCCGCCACACTTGA                                                                                                                       
  *Foxn4*                        F: CGAGCGAGCACTTTGGTGAC        94                 [NM_148935](http://www.ncbi.nlm.nih.gov/nuccore/91598890)    Amacrine development \[[@r39]\]
  R: AGGAGCAGATGTGAGCCATGATAA                                                                                                                   
  *Delta1*                       F: AGGGTGTGATGACCAACATGGA      96                 [NM_007865](http://www.ncbi.nlm.nih.gov/nuccore/164565442)   Notch pathway
  R: TATCGGATGCACTCATCGCAGTA                                                                                                                    
  *Notch1*                       F: CTCCAACTGTGACACCAACC        108                [NM_008714](http://www.ncbi.nlm.nih.gov/nuccore/224967064)   Notch pathway
  R: GCACCCAGATCACACTCATC                                                                                                                       
  *Hes1*                         F: CCAATTTGCCTTTCTCATCC        112                [NM_008235](http://www.ncbi.nlm.nih.gov/nuccore/31560817)    Notch pathway
  R: GGAAGGTGACACTGCGTTAG                                                                                                                       
  *GAPDH*                        F: CCTGCGACTTCAACAGCAACTC      119                [NM_008084](http://www.ncbi.nlm.nih.gov/nuccore/126012538)   Housekeeping gene
  R: GTTGCTGTAGCCGTATTCATTGTCA                                                                                                                  

Bromodeoxyuridine labeling
--------------------------

To label the proliferation- and differentiation-cultured RPCs, 1 µM BrdU (B-9285; Sigma) was added to the medium to incubate for 48 h. Then the BrdU was removed by rinsing twice with PBS solution. The proliferation-cultured RPCs were replated onto PDL-coated plates to allow attachment for another 4--6 h. The labeled RPCs were fixed with 4% paraformaldehyde before immunofluorescence detection.

Immunofluorescence
------------------

RPCs were collected and fixed in 4% paraformaldehyde for 15 min at room temperature. After blocking with 4% BSA in PBS containing 0.2%--0.5% Triton X-100 for 1 h, RPCs were incubated with the primary antibody, which included mouse anti-Nestin (1:100; MAB353; Millipore, Temecula, CA), mouse anti-BrdU (1:50; MAB3510; Millipore), goat anti-Brn3b (1:200; sc-31987; Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-GFAP (1:300; MAB353; Millipore), mouse anti-Map2 (1:50; Boster, Wuhan, China), rabbit anti-rhodopsin (1: 200; MAB5356; Chemicon), and rabbit anti-glutamine synthetase (1: 50; ab16802; Abcam, Cambridge, UK). After incubating with primary antibodies at 4 °C overnight, RPCs were rinsed 5 min in PBS for 4 times. Then they were incubated with the secondary antibodies, including rhodamine-conjugated anti-goat IgG (1:200; sc-2094; Santa Cruz), Cy3-conjugated anti-mouse IgG (1:100; C2181; Sigma), Alexa Fluor 488-conjugated anti-mouse IgG (1:800; A-21202; Molecular Probes) and Cy3-conjugated anti-rabbit IgG (1:50; BA1032; Boster), for about 1 h at room temperature. Hoechst 33342 (Invitrogen, Carlsbad, CA) was used for counterstaining. A negative control was performed by replacing the primary antibody with goat serum (16210--064; Gibco), mouse serum (10410; Invitrogen), or rabbit serum (16120--099; Gibco). Fluorescence was excited and detected using a confocal microscope (LSM 510 MEH, Carl Zeiss, Jena, Germany) or fluorescence microscope (Axioplan 2, Zeiss). Each experiment was repeated twice. Image-Pro Plus 6.0 software was used to analyze the results.

Results
=======

Gene expression in E13.5 retinal progenitor cells relative to E17.5 retinal progenitor cells
--------------------------------------------------------------------------------------------

To learn about the differential competence between freshly harvested E13.5 and E17.5 RPCs in molecular level, the expression of 14 key genes involved in retinal development was investigated by quantitative reverse transcription-PCR (RT--PCR). The expression level of each gene in fresh E17.5 RPCs was defined as 1. The results showed that the expression of *Nestin* (neural progenitor marker), *Hes1* (Notch1 effector), and the retinal ganglion cell (RGC)-related genes, including *Math5, Brn3b, Islet1*, and *Nfl*, were significant higher in E13.5 RPCs than in E17.5 RPCs (n=4, [Figure 1A](#f1){ref-type="fig"}, black column). In contrast, *Thy1, Nrl*, and *GFAP*, which are involved in synaptogenesis, the development of the rod photoreceptors, and the development of the glial cells, respectively, showed higher expression in E17.5 RPCs (n=4, [Figure 1B](#f1){ref-type="fig"}, black column). The gene expression patterns in E13.5 and E17.5 RPCs were generally consistent with the birth of stage-specific retinal cells in vivo \[[@r5],[@r6]\].

![Gene expression in freshly harvested or proliferation-cultured E13.5 retinal progenitor cells (RPCs) relative to fresh E17.5 RPCs. Expression of each gene in freshly harvested E17.5 RPCs was defined as 1. The columns represent the relative expression level in E13.5 RPCs, which were either freshly harvested (black column) or proliferation-cultured for 4 days (red column). Panel **A** shows the genes whose initial expression was high in fresh E13.5 RPCs, but mostly decreased after 4 days culture. Panel **B** represents those genes whose initial expression was low in fresh E13.5 RPCs, but increased after 4 days culture. Note that the expression change of *Math5, Brn3b*, and *Islet1* in E13.5 RPCs was exceptional. The symbols \* and \*\* represent p\<0.05 and p\<0.01, respectively, versus fresh E17.5 RPCs. The symbols \# and \#\# represent p\<0.05 or p\<0.01, respectively, versus fresh E13.5 RPCs. Data was mean±standard deviation (n=4). The significance was estimated by one-way ANOVA.](mv-v15-2503-f1){#f1}

Proliferation-culture of RPCs in vitro is often necessary to obtain enough seed cells. The developmental interval between E13.5 and E17.5 is 4 days. To explore the change of gene expression in vitro, the freshly-harvested E13.5 RPCs were proliferation-cultured in vitro for 4 days before the gene expression was detected by quantitative RT--PCR. The results showed that the expression level of most genes changed. In the 14 genes detected, the expression levels of 11 genes in E13.5 RPCs were closer to those in the freshly harvested E17.5 RPCs, including *GFAP, Nrl, Nfl, Pax6*, and *Rx* ([Figure 1](#f1){ref-type="fig"}). Though not all the changes were statistically significant, which may have been due to the small sample size, the tendency to change toward E17.5 RPCs was obviously. The tendency to change in gene expression implied that, when proliferation-cultured in vitro, E13.5 RPCs could continue their intrinsic development to some extent, though not as completely as in vivo.

Interestingly, the expression of several RGC-related genes, *Math5, Brn3b*, and *Islet1*, increased in E13.5 RPCs after 4 days of proliferation ([Figure 1A](#f1){ref-type="fig"}), which was opposite the developmental direction of 17.5 RPCs. The unexpected results might partially have resulted from the purification effect of the suspension culture, which will be discussed in the following section.

Proliferation- and differentiation-culture of E13.5 and E17.5 RPCs in vitro
---------------------------------------------------------------------------

To explore the gene expression and differentiation capacity of E13.5 and E17.5 RPCs in vitro, we harvested the freshly isolated E13.5 and E17.5 RPCs and cultured them in proliferation and differentiation conditions.

In the proliferation culture, both E13.5 and E17.5 RPCs began suspension growth and formed neurospheres ([Figure 2](#f2){ref-type="fig"}). Some researchers have indicated that the RPCs in these developmental stages are mostly immature progenitor cells \[[@r6],[@r17],[@r21]\]. To confirm that the RPCs in our study were still in an undifferentiated state after 4 days of proliferation culture, expression of Nestin, a neural progenitor marker, was investigated. The results showed that most cells in E13.5 and E17.5 RPCs expressed Nestin (82% and 87%, respectively; [Figure 3](#f3){ref-type="fig"}). Similarly, about 71% and 74% cells in E13.5 and E17.5 RPCs, respectively, incorporated BrdU after 48 h exposure ([Figure 3](#f3){ref-type="fig"}). Furthermore, no evident expression of mature retinal/neural marker could be detected in the 4 days proliferation-cultured RPCs ([Figure 4](#f4){ref-type="fig"}). These results suggested that both RPCs were still in an undifferentiated state, and that they continued to actively renew after 4 days of proliferation culture.

![E13.5 and E17.5 RPCs cultured in proliferation and differentiation conditions. Both RPCs adopted suspension growth and formed neurospheres in proliferation culture (**A**, **C**). After starting the differentiation culture, E13.5 and E17.5 RPCs became adherent growth and initiated differentiation by displaying stretched-out processes (**B**, **D**). Note that the processes in E13.5 RPCs (**B**) were long and thick, while in E17.5 RPCs (**D**) they were mainly short and thin. Bars were 50 μm.](mv-v15-2503-f2){#f2}

![*Nestin* expression and BrdU incorporation in RPCs before and after differentiation. The 4 day proliferation-cultured E13.5 and E17.5 RPCs were of differentiation-cultured. Before and after 8 day of differentiation, *Nestin* expression and BrdU incorporation were detected. Note that before differentiation, the expression of Nestin in both RPCs was vigorous, but significantly decreased after 8 days of differentiation (**A--D**, **I**). Similarly, the incorporation ratio of BrdU in both RPCs decreased dramatically after differentiation (**E--H**, **J**). Bars were 20 μm. Data in **I** and **J** is mean±standard deviation (n=3). The significance was determined by the Student *t*-test. The symbol \*\* represents p\<0.01 versus before differentiation.](mv-v15-2503-f3){#f3}

![Detection of the mature retinal markers in the proliferation-cultured E13.5 RPCs. After 4 day proliferation culture in vitro, E13.5 RPCs showed no obvious expression of the mature retinal markers *Rhodopsin* (**A-C**), *Map2* (**D-F**), or *GS* (**G-I**). Bars were 20 μm.](mv-v15-2503-f4){#f4}

To induce RPC differentiation, the suspended neurospheres were dissociated by trypsinization and then seeded onto a PDL-coated coverslip to allow attachment. Differentiation of both RPCs was confirmed by the significant downregulation of Nestin expression and the BrdU incorporation ratio ([Figure 3](#f3){ref-type="fig"}). The decrease of Nestin during RPC differentiation was similar to that previously reported \[[@r22]\]. Morphologically, after being differentiation-cultured for about 8 days, E13.5 RPC stretched out long and thick processes, while E17.5 RPCs mainly displayed short and thin processes ([Figure 2](#f2){ref-type="fig"}).

Gene expression in E13.5 and E17.5 RPCs under proliferation and differentiation conditions
------------------------------------------------------------------------------------------

The differential gene expression between freshly harvested E13.5 and E17.5 RPCs verified their different competences \[[@r5],[@r6]\]. To explore their specific differentiation capacity in vitro, the freshly harvested E13.5 and E17.5 RPCs were first proliferation-cultured for 4 days to allow some expansion, and then differentiation-cultured for 4 days or 8 days. The expression of some key genes involved in retinal development was explored at these points in time. The diagram of the experimental procedure is shown in [Figure 5](#f5){ref-type="fig"}.

![Diagram of gene expression detection in E13.5 and E17.5 RPCs under conditions of proliferation and differentiation culture. Total RNA was collected from four sources (circled numbers). Gene expression was detected by quantitative RT--PCR. To induce RPC differentiation, 2% fetal bovine serum was added to the growth medium in the adherent culture.](mv-v15-2503-f5){#f5}

[Figure 6](#f6){ref-type="fig"} shows the dynamic change in gene expression. *Math5, Brn3b*, and *Islet1* are key genes involved in RGCs development. Expression of these genes in E13.5 RPCs increased after 4 days of proliferation culture and then dramatically decreased during the 8 days of differentiation culture ([Figure 6A-C](#f6){ref-type="fig"}). The increase of *Math5, Brn3b*, and *Islet1* in E13.5 RPCs was exciting because it implied enrichment of retinal ganglion progenitors. Nevertheless, prolonging the proliferation culture up to 8 days showed that the increased expression of these genes could not be maintained ([Figure 7](#f7){ref-type="fig"}). On the other hand, the expression of these RGC-related genes in E17.5 RPCs kept decreasing both in proliferation and differentiation cultures ([Figure 6A-C](#f6){ref-type="fig"}). Though the expression of *Math5, Brn3b*, and *Islet1* evidently decreased in both RPCs during differentiation culture, the expression level of these genes was still significantly higher in E13.5 RPCs than in E17.5 RPCs after 8 days of differentiation ([Figure 6A-C](#f6){ref-type="fig"}).

![Gene expression in E13.5 and E17.5 RPCs under conditions of proliferation and differentiation culture. At 0 d: freshly harvested RPCs; 0--4 d: proliferation culture; 4--12 d: differentiation culture. (The detailed experimental procedure is shown in [Figure 5](#f5){ref-type="fig"}.) *GAPDH*, a housekeeping gene, served as an internal control. The insert in panel **B** was the local magnification at 12 days. Note the deviation bars at some points were almost indiscernible due to the large scale of the y-axis. The values were mean±standard deviation from three experiments. The symbols \* and \*\* represent p\<0.05 and p\<0.01, respectively, versus E17.5 RPCs (**A-D**) or E13.5 RPCs (**E-F**). The significance was determined by the Student *t*-test.](mv-v15-2503-f6){#f6}

![RGCs-related genes expression in E13.5 RPCs during 8 day proliferation culture The "X" letter in the y-axis represents *Brn3b, Math5, or Islet1*. *GAPDH* served as an internal control. Note that the expression of *Brn3b, Math5*, and *Islet1* weakly increased after 4 day culturing, followed by a dramatic decrease after 8 day. Data was mean±standard deviation (n=3).](mv-v15-2503-f7){#f7}

*Nfl* is another gene involved in RGCs development. The expression of Nfl kept decreasing in both RPCs, whether during proliferation or differentiation culture ([Figure 6D](#f6){ref-type="fig"}). Unlike *Math5, Brn3b*, or *Islet1*, a transient increase of *Nfl* in proliferative E13.5 RPCs was absent. The manner of differential expression between Nfl and each of *Math5, Brn3b*, or *Islet1*, suggests that they might be expressed in different cell subgroups or in different developmental stages.

*GFAP* and *Nrl* belong to glial and rod photoreceptor markers, respectively. Expression of these genes in both RPCs increased continuously during the proliferation and differentiation cultures ([Figure 6E-F](#f6){ref-type="fig"}). During differentiation culture, the increasing velocity of *GFAP* in E17.5 RPCs was obviously faster than in E13.5 RPCs ([Figure 6E](#f6){ref-type="fig"}), suggesting that E17.5 RPCs were more prone to differentiate toward glial cells than E13.5 RPCs. After 8 days of differentiation, expression of *GFAP* and *Nrl* was significantly higher in E17.5 RPCs than in E13.5 RPCs ([Figure 6E-F](#f6){ref-type="fig"}).

Protein expression in differentiated E13.5 and E17.5 RPCs
---------------------------------------------------------

To further explore the differentiation capacity of E13.5 and E17.5 RPCs in protein levels, both RPCs were induced to differentiate following the methods in [Figure 5](#f5){ref-type="fig"}. After 8 days, the expression of specific retinal markers was detected by immunofluorescence.

The results showed that the expression of the RGCs marker Brn3b and the neuronal marker Map2 in E13.5 RPCs was significantly higher than that in E17.5 RPCs (12.3% versus 3.6%, and 21.4% versus 6.4%, respectively; [Figure 8A-D,K](#f8){ref-type="fig"}). In contrast, the rod photoreceptor marker rhodopsin, the glial marker GFAP, and the Muller cell marker glutamine synthetase (GS) showed significantly higher expression in E17.5 RPCs ([Figure 8E-J,K](#f8){ref-type="fig"}). Morphologically, the GFAP- and glutamine synthetase-positive cells had a typical glial appearance.

![Immunofluorescence detection in differentiated E13.5 and E17.5 RPCs. After 8 days of differentiation, the expression of *Brn3b* (panel **A**, **B**), *Map2* (panel **C**, **D**), *GFAP* (panel **E**, **F**), glutamine synthetase (panel **G**, **H**), and Rhodopsin (panel **I**, **J**) in E13.5 and E17.5 RPCs was investigated. **K** is the statistical ratio of positive cells in both RPCs. Note that the expression ratios of *Brn3b* and *MAP2* in E13.5 RPCs were significantly higher than in E17.5 RPCs. In contrast, E17.5 RPCs expressed *GFAP*, glutamine synthetase (*GS*), and rhodopsin in higher percentages. The values were mean±standard deviation from three experiments. The symbols \* and \*\* represent p\<0.05 and p\<0.01, respectively, versus E13.5 RPCs. Bars were 20 μm. The significance was evaluated by the Student *t*-test.](mv-v15-2503-f8){#f8}

Discussion
==========

Gene expression and the competence of RPCs
------------------------------------------

Some researchers have quantitatively investigated the gene expression in RPCs at different developmental stages \[[@r17],[@r23]\]. However, in most of this research, gene expression was investigated by high-throughput gene arrays, which usually need to be confirmed by quantitative RT--PCR or in situ hybridizations \[[@r17],[@r23]\]. In the current study, we investigated the relative gene expression in RPCs by real-time quantitative RT--PCR, which was more sensitive than normal gene arrays.

E13.5 and E17.5 RPCs have different competences in vivo, and give rise to different retinal cell types \[[@r5],[@r6]\]. The birth of neural retinal cells results from the interaction of the retinal microenvironment and the intracellular cues of RPCs \[[@r4]\]. Our study of freshly harvested RPCs showed that E13.5 RPCs expressed RGC-related genes in high abundance. In contrast, the genes involved in synaptogenesis (*Thy1*) and late-stage retinal cell development, such as *Nrl* and *GFAP*, showed higher expression in E17.5 RPCs. These results were consistent with the reported competence of E13.5 and E17.5 RPCs in vivo \[[@r5],[@r6]\] and further verified the fundamental role of gene expression in RPC competence.

E13.5 and E17.5 retinal progenitor cells play different roles in retinal replacement therapy
--------------------------------------------------------------------------------------------

Many reports have held cell replacement therapy for retina-related diseases to be promising. Among various seed cells, RPCs have proved to be effective, and a better choice than others \[[@r1],[@r2],[@r24]\]. Among the heterogeneous RPCs transplanted into rod-defective retinas, Maclaren \[[@r1]\] found that the effective subgroup was exclusively comprised of post-mitotic rod precursors, which could integrate into host retinas and reestablish visual function. The effective cell subgroup was embodied by expressing the post-mitotic rod marker *Nrl* \[[@r1]\].

Our current research indicated that E13.5 RPCs had a high expression of the post-mitotic RGCs marker genes \[[@r25]-[@r27]\], such as *Math5, Brn3b*, and *Islet1*. This suggested that E13.5 RPCs contained more post-mitotic retinal ganglion precursors and could be a better choice for replacing degenerated RGCs, as compared to E17.5 RPCs. In contrast, E17.5 RPCs showed a high expression of the post-mitotic rod marker *Nrl,* and therefore could be a better choice for replacement therapy in the case of rod photoreceptor degeneration. The results of in vitro differentiation also supported this inference. After 8 days of differentiation, E13.5 RPCs contained more *Brn3b*- and *Map2*-positive cells, while E17.5 RPCs contained more rhodopsin-positive cells. Further investigation using an animal model would be necessary to confirm the in vivo therapeutic effect.

Expansion of RPCs in vitro is usually necessary to attain sufficient seed cells. There have been many reports that in vitro cultured RPCs could integrate into host retinas after transplantation \[[@r28]-[@r30]\]. However, little attention has been paid to the influence of in vitro culture on replacement therapy. Here, we can offer a preliminary conclusion based on the changes in gene expression. After 4 days of proliferation culture, expression of post-mitotic RGCs marker, including *Math5, Brn3b*, and *Islet1*, increased in E13.5 RPCs. Similarly, expression of the post-mitotic rod marker *Nrl* in E17.5 RPCs also increased after 4 days of proliferation. Therefore, the proliferation culture of E13.5 and E17.5 RPCs in vitro for 4 days may enhance their respective efficiency in replacement therapy. However, the effect of long-term proliferation culture on replacement therapy may be different. There have been reports of long-term culture resulting in reprogramming of RPCs to a more primordial state, which somewhat affected the replacement therapy \[[@r31]\].

Development continued in retinal progenitor cells when proliferation-cultured in vitro
--------------------------------------------------------------------------------------

Some research shows that the proliferation-cultured RPCs could maintain their proliferation properties or differentiation capacity for a fairly long time \[[@r31],[@r32]\]; however, this research is preliminary. The quantitative detection of gene expression, which is an important indicator of cell competence, was lacking.

Our results showed that gene expression changed rapidly and dramatically when E13.5 or E17.5 RPCs were proliferation-cultured in vitro. Since gene expression plays a key role in RPCs competence, we infer that the competence of RPCs should also change over time. Therefore, culture time should be an important factor to be considered before RPCs are transplanted.

The changing direction of gene expression in proliferation-cultured RPCs generally followed that of retinal development. After 4 days of expansion in vitro, most gene expression in E13.5 RPCs came close to that of fresh E17.5 RPCs. Similarly, in the proliferated E17.5 RPCs, expression of *GFAP* and *Nrl* increased, and expression of *Math5, Brn3b*, and *Islet1* decreased, after 4 days of culture. This was consistent with the developmental tendency in late-embryonic retinas.

The tendency to change in gene expression suggested that proliferation-cultured E13.5 and E17.5 RPCs could continue their development to some degree. Exceptionally, the expression of Math5, Brn3b, and Islet1 in E13.5 RPCs increased after 4 days of proliferation culture, which was opposite the developmental direction toward E17.5 RPCs. Several reasons may account for this result. The first was selective purification of E13.5 RPCs during suspension culture. RPCs derived from immature retinas were heterogeneous due to the retinal structure and the manual operation in harvesting RPCs. During the suspended-proliferation culture, some adherent cells showing epithelial-like or spindle shapes were observed, and they were excluded from the ensuing experiments. Therefore, suspension culture may be a purification procedure for RPCs. The second reason may be due to a limited amplification of retinal ganglion progenitors, since the generation of RGCs peaks from E13.5 to E15.5 \[[@r6],[@r27]\]. Furthermore, maturation of RGCs during 4 days of proliferation culture could also result in the upregulation of RGC-related genes.

In theory, among the various seed cells, there should exist a cell or subgroup of cells that could most efficiently integrate into the recipient and rebuild biologic function. Finding the best seed cells and then thoroughly exploring their biologic characteristics, especially their specific gene expression, would make it possible to produce massive quantities of such cells by molecular biologic technologies. This study has shed some light on the gene expression and differentiation characteristics in mouse E13.5 and E17.5 RPCs, and has provided some clues to selecting right-timing RPCs. Further confirmation of these right-timing RPCs in an animal model will be necessary. Investigating the right-timing RPCs might be the right way to find the best seed cells for retina replacement therapy.
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